Benzinga’s Top Ratings Upgrades, Downgrades For December 9, 2021
Upgrades
According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:NVEI) was changed from Market Perform to Outperform.
JP Morgan Initiates Coverage On RAPT Therapeutics with Overweight Rating, Announces Price Target of $61
JP Morgan analyst Anupam Rama initiates coverage on RAPT Therapeutics (NASDAQ:RAPT) with a Overweight rating and announces Price Target of $61.
RAPT Therapeutics Q3 EPS $(0.63) Down From $(0.60) YoY, Sales $966.00K Down From $1.53M YoY
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is a 5 percent decrease over losses of $(0.60) per share from the same period last year. The company reported $966.00 thousand in
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
How Good Are RAPT Therapeutics’s Earnings? | Return On Capital Employed
According to Benzinga Pro data, during Q2, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $869.00 thousand. Earnings were up 2.9%, but RAPT Therapeutics still reported an overall loss of $16.08 million.
SVB Leerink Initiates Coverage On RAPT Therapeutics with Outperform Rating, Announces Price Target of $49
SVB Leerink analyst Thomas Smith initiates coverage on RAPT Therapeutics (NASDAQ:RAPT) with a Outperform rating and announces Price Target of $49.
RAPT Therapeutics Q2 EPS $(0.63) Down From $(0.51) YoY, Sales $869.00K Down From $1.28M YoY
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is a 23.53 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $869.00 thousand in
10 Biggest Price Target Changes For Wednesday
Wedbush boosted Microsoft Corporation (NASDAQ: MSFT) price target from $310 to $325. Microsoft shares slipped 0.1% to $265.48 in pre-market trading.
